Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Beck

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reviews|December 1, 1990
Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factorsW T Beck
Cancer Treatment and Research|January 1, 1991
Modulators of P-glycoprotein-associated multidrug resistanceW T Beck
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Multidrug resistance and its circumventionW T Beck
Bulletin Du Cancer|January 1, 1990
Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topoisomerase IIW T Beck
Journal of the National Cancer Institute|January 18, 1995
Circumvention of multidrug resistance with anti-P-glycoprotein antibodies: clinical potential or experimental artifact?W T Beck
Biochemical Pharmacology|September 15, 1987
The cell biology of multiple drug resistanceW T Beck
Cancer Treatment Reports|October 1, 1983
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblastsW T Beck
Biochemical Pharmacology|September 1, 1980
Increase by vinblastine of oxidized glutathione in cultured mammalian cellsW T Beck
Advances in Enzyme Regulation|January 1, 1984
Cellular pharmacology of Vinca alkaloid resistance and its circumventionW T Beck
Journal of the National Cancer Institute|October 2, 1991
Do anti-P-glycoprotein antibodies have a future in the circumvention of multidrug resistance?W T Beck
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reviews|December 1, 1990
Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factorsW T Beck
Cancer Treatment and Research|January 1, 1991
Modulators of P-glycoprotein-associated multidrug resistanceW T Beck
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Multidrug resistance and its circumventionW T Beck
Bulletin Du Cancer|January 1, 1990
Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topoisomerase IIW T Beck
Journal of the National Cancer Institute|January 18, 1995
Circumvention of multidrug resistance with anti-P-glycoprotein antibodies: clinical potential or experimental artifact?W T Beck
Biochemical Pharmacology|September 15, 1987
The cell biology of multiple drug resistanceW T Beck
Cancer Treatment Reports|October 1, 1983
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblastsW T Beck
Biochemical Pharmacology|September 1, 1980
Increase by vinblastine of oxidized glutathione in cultured mammalian cellsW T Beck
Advances in Enzyme Regulation|January 1, 1984
Cellular pharmacology of Vinca alkaloid resistance and its circumventionW T Beck
Journal of the National Cancer Institute|October 2, 1991
Do anti-P-glycoprotein antibodies have a future in the circumvention of multidrug resistance?W T Beck
Pageof 11